ArticleCancer2017

The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.

Mark M Pomerantz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.